Company Filing History:
1 out of 269 
1 out of 2 Years Active: 2022
Title: Changda Liu: Innovator in Immunological Treatments
Introduction
Changda Liu is a notable inventor based in New York, NY (US). He has made significant contributions to the field of immunology through his innovative research and development. His work focuses on the treatment of immunological diseases, showcasing his commitment to advancing medical science.
Latest Patents
Changda Liu holds a patent for the "Treatment of immunological disease using berberine nanoparticles." This patent outlines methods for treating immunological conditions, such as allergies, through the administration of berberine nanoparticles. His innovative approach has the potential to improve treatment options for patients suffering from these conditions. He has 1 patent to his name.
Career Highlights
Throughout his career, Changda Liu has worked with prestigious institutions, including the Icahn School of Medicine at Mount Sinai and the Sean N. Parker Foundation. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Changda Liu has collaborated with notable colleagues, including Xiu-Min Li and Kamal Srivatava. These partnerships have enhanced his research efforts and expanded the impact of his work in immunology.
Conclusion
Changda Liu is a dedicated inventor whose work in immunological treatments is paving the way for new therapeutic options. His innovative use of berberine nanoparticles demonstrates his commitment to improving patient care and advancing medical research.